Latest AI and machine learning research in skin cancer for healthcare professionals.
Immune checkpoint inhibitors (ICIs) benefit only a subset of patients with metastatic non-small cell lung cancer (NSCLC), but current selection relies on tissue PD-L1 immunohistochemistry (IHC), which is invasive and prone to sampling bias. We developed and validated SCENT (Scalable Ensemble Transformer), a CT-based deep learning model for noninvasive prediction of PD-L1 status and immunotherapy o...
T cell receptors (TCRs) are central to adaptive immunity, yet their vast sequence and structural diversity present a significant challenge to fully understand immune responses. The application of high-throughput sequencing technologies, including bulk and single-cell approaches, generates vast datasets of TCR repertoire information, requiring advanced computational tools for meaningful analysis. H...
Accurate assessment of protein translation is crucial for understanding disease variant functions, but mRNA-protein discrepancy limits transcriptomics...
Tumor-educated platelets (TEPs) have recently emerged as an important component of liquid biopsy, yet the clinical relevance in colorectal cancer (CRC...
BACKGROUND: Membranous nephropathy (MN) is an autoimmune disease characterized by immune complex deposition and progressive renal function impairment....
Aging-related molecular reprogramming profoundly influences melanoma progression and therapeutic sensitivity, yet underlying mechanisms remain poorly ...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy in which liver metastasis represents the principal determinant of po...
The tumor microenvironment (TME) critically shapes disease progression and therapeutic resistance. However, a comprehensive understanding of its spati...
Conventional immune checkpoint inhibitors (ICIs) remain largely ineffective in microsatellite-stable metastatic colorectal cancer (MSS mCRC), where lo...
Skin cancer is among the most prevalent malignancies worldwide, with non-melanoma types ranking among the top five and melanoma characterized by high ...
Identifying tumor-specific T-cell antigens is essential for advancing cancer immunotherapy and enabling precision-driven, AI-assisted discovery. While...
The basement membrane (BM) plays a critical role in regulating bladder cancer (BC) progression. However, a BM-related signature for predicting BC recu...
OBJECTIVE: This study aims to construct a multimodal fusion model (FM) based on CT and hematoxylin and eosin (H&E) stained slices to predict the PD-L1...
BACKGROUND: Despite improved outcomes with atezolizumab plus bevacizumab (A+B) in hepatocellular carcinoma (HCC), primary refractoriness (PRef), chara...
Artificial intelligence (AI) algorithms such as ENLIGHT and DeepPT represent promising approaches to identify predictive biomarkers for immune checkpo...
Cell-free DNA can be used for early cancer detection, minimal residual disease monitoring, and post-treatment risk stratification. However, current as...
BRAF mutations are key oncogenic alterations across multiple malignancies, including melanoma, thyroid carcinoma, colorectal cancer, non-small cell lu...
Ultrasound has emerged as a versatile, non-invasive imaging technique in dermatology, offering real-time, high-resolution visualization of cutaneous s...
Resistance to immune checkpoint inhibitors is a major clinical obstacle in the treatment of gastric cancer. Identifying drug-resistant cell population...
Deep learning has rapidly emerged as a transformative technology in oncology, offering new capabilities in treatment response prediction and personali...